Dark Blue Therapeutics is reimagining the discovery ecosystem
Dependency on adaptive biology
Dependency on driver mutations
Leverage unique
target insights
Clear clinical line of sight to single agents in high unmet medical needs
Pipeline of first-in-class drugs with transformative potential. Click to see our PIPELINE
Deep pool of high potential precision medicine targets accessible via broad academic network
Pipeline of 1st in class drugs with transformative potential. Click to see our PIPELINE
We are agnostic of cancer mechanism and have proven capabilities to apply all chemical drug modes of action. This enables us to work on the most attractive targets, paired with the most effective chemistry to deliver transformational first-in-class drugs